The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.
Learn More >
See how Tetra is making history in scientific innovation through cutting edge drug development.
Tetra’s promising Alzheimer’s drug is being developed with the NIH Blueprint Therapeutics program.
Alzheimer’s disease | Dementias | Traumatic brain injury | Major psychiatric diseases | Neurodevelopmental disorders
Alzheimer’s Disease won’t treat itself. Are you willing to help?